Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Provexis (PXS) Is Turning Heads Against the FTSE AIM All-Share

Provexis plc (LSE:PXS) was among the most volatile UK stocks on 23 September 2026. The Reading-based company develops and sells Fruitflow, a tomato extract that it describes as scientifically proven to inhibit platelet aggregation, for use in dietary supplements and functional foods.

Ankur Sharma | 24 September 2026

Why Proteome Sciences (PRM) Is Suddenly a Volatility Magnet Against the FTSE AIM All-Share

Proteome Sciences plc (LSE:PRM), the AIM-quoted protein biomarker and mass-spectrometry specialist, was named among the most volatile UK stocks on 23 September 2026. The listing followed a busy fortnight: on 15 September the company confirmed a further GCLP-grade chemoproteomics contract, and on 16 September …

Ankur Sharma | 24 September 2026

Why Has ImmuPharma (LSE:IMM) Fallen 17.04% as Investors Reassess P140 and Kapiglucagon?

ImmuPharma plc —LSE:IMMis in focus on September 24, 2026, after its shares fell17.04%in the trading data provided.

Ankur Sharma | 24 September 2026

Could Provexis PLC (LSE:PXS) Unlock a New Growth Phase as Fruitflow Gains Fresh China Attention?

Provexis PLC (LSE:PXS) is attracting investor attention because it sits at the intersection ofhealthcare, functional foods and nutraceuticals, with Fruitflow representing the company's central commercial asset.

Ankur Sharma | 24 September 2026

Why AstraZeneca (AZN) Remains a Major FTSE 100 Stock to Watch

Those headlines follow first-half results in July that showedRevenueup 9% and coreEarnings Per Shareup 12%, with full-year guidance maintained. The company has also changed how its shares trade in the US, replacing its American Depositary Shares with a direct New York Stock Exchange listing …

Ankur Sharma | 24 September 2026

Could Futura Medical’s Eroxon expansion and new US commercial opportunity drive LSE:FUM higher after a 10.00% rise?

Futura Medical has attracted renewed attention afterLSE:FUM gained 10.00% on 24 September 2026.

Ankur Sharma | 24 September 2026

Cambridge Nutritional Sciences (LSE:CNSL) Rises 13.33%: Can Its New Growth Strategy Revive the Small-Cap Diagnostics Stock?

Cambridge Nutritional Sciences (LSE:CNSL) is back in focus after a13.33% share-price rise on 24 September 2026.

Ankur Sharma | 24 September 2026

BSF Enterprise Shares Swing Sharply on Licensing Deals, Patent News and Small Financings

BSF Enterprise has been showing high-beta characteristics. The company owns three tissue-engineering subsidiaries: Lab-Grown Leather Ltd, which has promoted a "T-Rex Leather" material; 3D Bio-Tissues Ltd (3DBT), which makes cell-culture products and the ETSYL collagen-boosting peptide; and Kerato Ltd, which is developing a liquid …

Divya Sood | 24 September 2026

hVIVO Shares Swing as Doubled Orderbook Meets Lower 2026 Revenue Outlook

hVIVO runs the world's largestQuarantineFacilityfor human challenge trials, in which healthy volunteers are deliberately exposed to a virus or bacterium so that aVaccineor antiviral can be tested quickly. The company is quoted on AIM, the London Stock Exchange's growth market, and has been showing …

Divya Sood | 24 September 2026

Shield Therapeutics Shares Make Outsized Moves as Medicaid Changes and US Control Deal Weigh

Shield Therapeutics plc has been showing high-beta characteristics. The Gateshead-headquartered company is a commercial-stage pharmaceuticalBusinessfocused on iron deficiency, and its main product is ACCRUFeR (ferric maltol), an oral iron therapy sold as FeRACCRU in Europe.

Divya Sood | 24 September 2026
Support

Hi! How can we help you today?

Loading…